Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II studyNiccolò Buetti, Étienne Ruppé, Alexis Tabah et al.|Critical Care|2022Cited by 58
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controlsAli Mert, Ahmet Gül, Atahan Çağatay et al.|Rheumatology International|2021Cited by 6
The clinical characteristics and the risk factors for mortality in Non-COVID-19 critical patients in a pandemic hospital in Turkey: a retrospective crosssectional studyBanu Çevik, Kemal Tolga Saraçoğlu|Malawi Medical Journal|2022Cited by 1